[SY10-1] SLAM family proteins as therapeutic targets in multiple myeloma
Professional Experience & Education
1990 M.D. Nippon Medical School
1990-1992 Resident, Department of Medicine, Nippon Medical School
1992-Present Department of Hematology, Nippon Medical School
1998 PhD (Doctorate in Medical Science), Nippon Medical School
1998-1999 Collaborative Researcher, Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan
1999-2001 Research Fellow, Department of Immunology (Prof. Lieping Chen), Mayo Clinic, MN, USA
2008 Assistant Professor, Division of Hematology, Department of Medicine, Nippon Medical School
2013 Associate Professor, Department of Hematology, Nippon Medical School
2014 Head, Department of Transfusion Medicine, Nippon Medical School (holding two concurrent posts)
Awards
2001 Maruyama Memorial Award
2002 Takeshi Nagao Research Fund
2014 Award in Aki Memory of International Myeloma Foundation
Research Interests
My research interests include regulation of antitumor immunity and development of immunotherapies for the treatment of hematological malignancies, especially multiple myeloma.
1990 M.D. Nippon Medical School
1990-1992 Resident, Department of Medicine, Nippon Medical School
1992-Present Department of Hematology, Nippon Medical School
1998 PhD (Doctorate in Medical Science), Nippon Medical School
1998-1999 Collaborative Researcher, Department of Immunology, National Institute of Infectious Diseases, Tokyo, Japan
1999-2001 Research Fellow, Department of Immunology (Prof. Lieping Chen), Mayo Clinic, MN, USA
2008 Assistant Professor, Division of Hematology, Department of Medicine, Nippon Medical School
2013 Associate Professor, Department of Hematology, Nippon Medical School
2014 Head, Department of Transfusion Medicine, Nippon Medical School (holding two concurrent posts)
Awards
2001 Maruyama Memorial Award
2002 Takeshi Nagao Research Fund
2014 Award in Aki Memory of International Myeloma Foundation
Research Interests
My research interests include regulation of antitumor immunity and development of immunotherapies for the treatment of hematological malignancies, especially multiple myeloma.
Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.